Disc Medicine Inc at JPMorgan Healthcare Conference Transcript
Good afternoon, everybody. Thank you so much for joining us on day three of the JP Morgan Healthcare Conference. My name is Bhavana Balakrishnan, and I'm an associate from the healthcare investment banking team.
We are here today for the presentation of Disc Medicine, and we're joined by John Quisel, Chief Executive Officer. And I'll turn it over to you, John.
Great. Thank you. All right. Great to be here. Thanks, everyone, for taking some time today. I guess Wednesday afternoon, we've reached maybe the exhaustion stage of the conference. But thanks to the JPMorgan team for providing a speaking slide for us here.
Okay. So we're about the three years public listed here at Disc. It's been an exciting run, highly productive. We look forward to next year being a really exciting year. We're on the cusp of approval of our lead program, and then we have a whole pipeline behind that progressing well. So we'll walk through all that
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
